Literature DB >> 25443551

Three sib-pairs of autopsy-confirmed progressive supranuclear palsy.

Shinsuke Fujioka1, Monica Y Sanchez Contreras2, Audrey J Strongosky3, Kotaro Ogaki2, Nathaniel Robb Whaley4, Pawel M Tacik3, Jay A van Gerpen3, Ryan J Uitti3, Owen A Ross2, Zbigniew K Wszolek5, Rosa Rademakers2, Dennis W Dickson6.   

Abstract

OBJECTIVE: To describe the clinical, pathological, and genetic features of three sib-pairs of pathologically-confirmed progressive supranuclear palsy (PSP).
METHODS: We searched the Mayo Clinic neurodegenerative diseases brain bank for cases of PSP in which more than one family member had pathologically-confirmed PSP. Clinical and pathological data were reviewed and all individuals were screened for mutations in MAPT, by sequencing exons 1, 7, and 9-13.
RESULTS: We identified three sib-pairs of pathologically-confirmed PSP. Sufficient information was available to suggest an autosomal dominant inheritance in two. The mean age at symptom onset was 41 years in one pair, and 76 years in the other two. The young onset pair had a p.S285R mutation in MAPT, but no mutations were detected in the other two.
CONCLUSIONS: All sib-pairs had typical pathological features of PSP; however, the age at onset of the sib-pair with MAPT mutation was significantly younger than sporadic PSP. Future studies are warranted to identify a possible genetic basis for PSP associated with late onset and typical PSP pathology.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MAPT; Progressive supranuclear palsy; p.S285R; tau pathology

Mesh:

Substances:

Year:  2014        PMID: 25443551      PMCID: PMC4306617          DOI: 10.1016/j.parkreldis.2014.10.028

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  12 in total

1.  Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene.

Authors:  P Pastor; E Pastor; C Carnero; R Vela; T García; G Amer; E Tolosa; R Oliva
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

Review 2.  Progressive supranuclear palsy.

Authors:  Bradley F Boeve
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

3.  G303V tau mutation presenting with progressive supranuclear palsy-like features.

Authors:  Ariane Choumert; Alice Poisson; Jérôme Honnorat; Isabelle Le Ber; Agnes Camuzat; Emmanuel Broussolle; Stéphane Thobois
Journal:  Mov Disord       Date:  2011-11-22       Impact factor: 10.338

Review 4.  Neuropathology of variants of progressive supranuclear palsy.

Authors:  Dennis W Dickson; Zeshan Ahmed; Avi A Algom; Yoshio Tsuboi; Keith A Josephs
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

Review 5.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Authors:  I Litvan; Y Agid; D Calne; G Campbell; B Dubois; R C Duvoisin; C G Goetz; L I Golbe; J Grafman; J H Growdon; M Hallett; J Jankovic; N P Quinn; E Tolosa; D S Zee
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

Review 6.  Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

Authors:  J J Hauw; S E Daniel; D Dickson; D S Horoupian; K Jellinger; P L Lantos; A McKee; M Tabaton; I Litvan
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

7.  Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP.

Authors:  H R Morris; Y Osaki; J Holton; A J Lees; N W Wood; T Revesz; N Quinn
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

8.  The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.

Authors:  Salvatore Spina; Martin R Farlow; Frederick W Unverzagt; David A Kareken; Jill R Murrell; Graham Fraser; Francine Epperson; R Anthony Crowther; Maria G Spillantini; Michel Goedert; Bernardino Ghetti
Journal:  Brain       Date:  2007-12-07       Impact factor: 13.501

9.  An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype.

Authors:  Parvoneh Poorkaj; Nancy A Muma; Victoria Zhukareva; Elizabeth J Cochran; Kathleen M Shannon; Howard Hurtig; William C Koller; Thomas D Bird; John Q Trojanowski; Virginia M-Y Lee; Gerard D Schellenberg
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

10.  Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy.

Authors:  Shinsuke Fujioka; Avi A Algom; Melissa E Murray; Audrey Strongosky; Alexandra I Soto-Ortolaza; Rosa Rademakers; Owen A Ross; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Neurology       Date:  2013-05-01       Impact factor: 9.910

View more
  13 in total

1.  LRP10 variants in progressive supranuclear palsy.

Authors:  Leonie J M Vergouw; Shamiram Melhem; Laura Donker Kaat; Wang Z Chiu; Demy J S Kuipers; Guido Breedveld; Agnita J W Boon; Li-San Wang; Adam C Naj; Elizabeth Mlynarksi; Laura Cantwell; Marialuisa Quadri; Owen A Ross; Dennis W Dickson; Gerard D Schellenberg; John C van Swieten; Vincenzo Bonifati; Frank Jan de Jong
Journal:  Neurobiol Aging       Date:  2020-04-30       Impact factor: 4.673

Review 2.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

3.  Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.

Authors:  Naomi Kouri; Owen A Ross; Beth Dombroski; Curtis S Younkin; Daniel J Serie; Alexandra Soto-Ortolaza; Matthew Baker; Ni Cole A Finch; Hyejin Yoon; Jungsu Kim; Shinsuke Fujioka; Catriona A McLean; Bernardino Ghetti; Salvatore Spina; Laura B Cantwell; Martin R Farlow; Jordan Grafman; Edward D Huey; Mi Ryung Han; Sherry Beecher; Evan T Geller; Hans A Kretzschmar; Sigrun Roeber; Marla Gearing; Jorge L Juncos; Jean Paul G Vonsattel; Vivianna M Van Deerlin; Murray Grossman; Howard I Hurtig; Rachel G Gross; Steven E Arnold; John Q Trojanowski; Virginia M Lee; Gregor K Wenning; Charles L White; Günter U Höglinger; Ulrich Müller; Bernie Devlin; Lawrence I Golbe; Julia Crook; Joseph E Parisi; Bradley F Boeve; Keith A Josephs; Zbigniew K Wszolek; Ryan J Uitti; Neill R Graff-Radford; Irene Litvan; Steven G Younkin; Li-San Wang; Nilüfer Ertekin-Taner; Rosa Rademakers; Hakon Hakonarsen; Gerard D Schellenberg; Dennis W Dickson
Journal:  Nat Commun       Date:  2015-06-16       Impact factor: 14.919

4.  Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.

Authors:  Melissa C Wren; Jing Zhao; Chia-Chen Liu; Melissa E Murray; Yuka Atagi; Mary D Davis; Yuan Fu; Hirotaka J Okano; Kotaro Ogaki; Audrey J Strongosky; Pawel Tacik; Rosa Rademakers; Owen A Ross; Dennis W Dickson; Zbigniew K Wszolek; Takahisa Kanekiyo; Guojun Bu
Journal:  Mol Neurodegener       Date:  2015-09-15       Impact factor: 14.195

5.  Familial atypical parkinsonism with rare variant in VPS35 and FBXO7 genes: A case report.

Authors:  Tereza Bartonikova; Katerina Mensikova; Lenka Mikulicova; Radek Vodicka; Radek Vrtel; Marek Godava; Miroslav Vastik; Michaela Kaiserova; Pavel Otruba; Iva Dolinova; Martin Nevrly; Petr Kanovsky
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Authors:  Shelley L Forrest; Jillian J Kril; Claire H Stevens; John B Kwok; Marianne Hallupp; Woojin S Kim; Yue Huang; Ciara V McGinley; Hellen Werka; Matthew C Kiernan; Jürgen Götz; Maria Grazia Spillantini; John R Hodges; Lars M Ittner; Glenda M Halliday
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

7.  Heritability in frontotemporal tauopathies.

Authors:  Shelley L Forrest; Glenda M Halliday; Heather McCann; Andrew B McGeachie; Ciara V McGinley; John R Hodges; Olivier Piguet; John B Kwok; Maria G Spillantini; Jillian J Kril
Journal:  Alzheimers Dement (Amst)       Date:  2019-01-24

8.  Slowly progressive dementia caused by MAPT R406W mutations: longitudinal report on a new kindred and systematic review.

Authors:  Emil Ygland; Danielle van Westen; Elisabet Englund; Rosa Rademakers; Zbigniew K Wszolek; Karin Nilsson; Christer Nilsson; Maria Landqvist Waldö; Irina Alafuzoff; Oskar Hansson; Lars Gustafson; Andreas Puschmann
Journal:  Alzheimers Res Ther       Date:  2018-01-09       Impact factor: 6.982

9.  Latent trait modeling of tau neuropathology in progressive supranuclear palsy.

Authors:  Naomi Kouri; Melissa E Murray; Joseph S Reddy; Daniel J Serie; Alexandra Soto-Beasley; Mariet Allen; Minerva M Carrasquillo; Xue Wang; Monica Casey Castanedes; Matthew C Baker; Rosa Rademakers; Ryan J Uitti; Neill R Graff-Radford; Zbigniew K Wszolek; Gerard D Schellenberg; Julia E Crook; Nilüfer Ertekin-Taner; Owen A Ross; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2021-02-26       Impact factor: 17.088

Review 10.  Genetics of Progressive Supranuclear Palsy.

Authors:  Sun Young Im; Young Eun Kim; Yun Joong Kim
Journal:  J Mov Disord       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.